AC Immune Ltd (ACIU) — Cash Flow-to-Debt Ratio
AC Immune Ltd (ACIU) has a Cash Flow-to-Debt Ratio of -0.15x as of December 2025, meaning its operating cash flow of $-16.45 Million could theoretically repay 0% of its total liabilities ($109.49 Million) in one year. Explore ACIU long-term investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
AC Immune Ltd Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for AC Immune Ltd across 13 annual periods. Also explore AC Immune Ltd (ACIU) total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for AC Immune Ltd (2013–2025)
Year-by-year debt coverage analysis for AC Immune Ltd. For market capitalisation and broader financial context, see AC Immune Ltd market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.60x | $-66.15 Million | $109.49 Million | ▼ -208.9% |
| 2024 | 0.55x | $65.84 Million | $118.64 Million | ▲ +120.4% |
| 2023 | -2.72x | $-60.41 Million | $22.17 Million | ▲ +37.2% |
| 2022 | -4.34x | $-73.57 Million | $16.95 Million | ▼ -94.7% |
| 2021 | -2.23x | $-65.69 Million | $29.46 Million | ▲ +12.9% |
| 2020 | -2.56x | $-59.52 Million | $23.26 Million | ▼ -224.2% |
| 2019 | 2.06x | $55.22 Million | $26.81 Million | ▲ +188.5% |
| 2018 | -2.33x | $-44.08 Million | $18.93 Million | ▼ -59.9% |
| 2017 | -1.46x | $-22.09 Million | $15.17 Million | ▼ -253.8% |
| 2016 | -0.41x | $-5.65 Million | $13.72 Million | ▼ -108.3% |
| 2015 | 4.96x | $44.08 Million | $8.89 Million | ▲ +292.2% |
| 2014 | -2.58x | $-17.62 Million | $6.83 Million | ▼ -2.8% |
| 2013 | -2.51x | $-19.80 Million | $7.89 Million | — |